Reductions in class 3 semaphorins were observed, which could enhance VEGF signaling by making more NRP1 available; lower Sema3 levels could also enhance angiogenesis by removing inhibitory signals mediated by plexins (i.e. the brakes on tumor angiogenesis are removed). The gene discussed is NRP1; the disease is neoplasm.